Blog Topic: Coping with cancer
Professor Jennifer Martin has been researching into personalised chemotherapy dosing for some time. Now Professor Martin and her team are moving into the trial stage of their research. The dosing study known as the PREDICT (Pathway of Research to Evaluation of Dose-Individualised Cancer Therapy) Program uses new technology to find the ideal chemotherapy dosage for […]
Before her diagnosis, the only thing Brenda Blackmore really knew about pancreatic cancer was that it had claimed the life of Dirty Dancing’s Patrick Swayze. “I wasn’t aware of pancreatic cancer, aside from hearing about the celebrities who had died from it,” Brenda said. At age 69, pancreatic cancer was last thing on the McMahons […]
Check out our new podcast series, The Thing About Advanced Cancer. Podcasts are an increasingly popular medium around the world. At first glance, they might seem like a step back in an age when video content is so prevalent, but the audio storytelling format has many advantages. Podcasts are a great format to fit into […]
Last week, the fourth national (and the largest so far) Cancer Survivorship Conference took place in Sydney, Australia. Speakers and guests explored the theme of “Future of Cancer Survivorship: Evolution or Revolution?”, covering topics such as: Cost of cancer – at an individual and societal level Cardio-toxicity of cancer treatment and cardiovascular disease after cancer […]
Personalised chemotherapy dosing can improve patient outcomes. You play an important part in creating a cancer free future. This year, with your help, more than $10 million has been awarded to 17 new outstanding research projects, investigating new ways to treat cancer.
Thanks to advancements in cancer research, new treatment options and drugs are being tested and developed to improve outcomes for cancer patients. Targeted therapy is a promising drug treatment that attacks specific features of cancer cells, known as molecular targets, to stop the cancer growing and spreading. The development of targeted therapy drugs has led […]
“Did you smoke?” This is probably the most common question that lung cancer patients and survivors are faced with after their diagnosis. And it’s an issue: the stigma attached to a lung cancer diagnosis results in physical, psychological and societal harm that doesn’t get addressed frequently enough. Today, I’m speaking at the Australian Lung Cancer […]